WuXi STA expects to hire about 500 people in the coming years to support Phase 1 of the manufacturing campus. A Chinese pharmaceutical company is moving forward with plans to build a massive $510 ...

FDA-approved T-cell cancer therapy (a technology pioneered in Philadelphia), and name-brand research products. WuXi AppTec said the sale covered its U.S. and U.K. Advanced Therapies facilities.

Employees of Sovereign Security say only a few banks will cash their checks and only after checking there's money available to pay them.

Philadelphia, Pennsylvania and Oxford ... Allo-T program to be featured at the Biotech ShowCase(TM) and the Wuxi Global Forum 2025Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile ...

But Kelly convened members recently to talk about the region’s biomanufacturing future after the China-based owners of the region’s biggest gene and cell therapy manufacturing facility, WuXi ...

The total shares sold accounted for about 7.2 percent of WuXi XDC's total equity. The company, which is named in the proposed US Biosecure Act, announced the sale of its cell and gene therapy units -- ...

They call themselves Speed to Market, a group of life sciences and real estate professionals who find, build, and sell manufacturing space for biotech employers around Philadelphia ... therapy ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

Super Bowl 2025 is going to take place on February 9, 2025, in New Orleans where Kansas City Chiefs and Philadelphia Eagles ...

WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released lower-than ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

Plans for the project were submitted to the Philadelphia Civic Design Review committee and will be reviewed in February, and the project will go in front of the Zoning Board of Adjustment later in ...